Kidney dosimetry in [177Lu]Lu-DOTA-TATE therapy based on multiple small VOIs

Phys Med. 2024 Apr:120:103335. doi: 10.1016/j.ejmp.2024.103335. Epub 2024 Mar 30.

Abstract

Purpose: The aim was to investigate the use of multiple small VOIs for kidney dosimetry in [177Lu]Lu-DOTA-TATE therapy.

Method: The study was based on patient and simulated SPECT images in anthropomorphic geometries. Images were reconstructed using two reconstruction programs (local LundaDose and commercial Hermia) using OS-EM with and without resolution recovery (RR). Five small VOIs were placed to determine the average activity concentration (AC) in each kidney. The study consisted of three steps: (i) determination of the number of iterations for AC convergence based on simulated images; (ii) determination of recovery-coefficients (RCs) for 2 mL VOIs using a separate set of simulated images; (iii) assessment of operator variability in AC estimates for simulated and patient images. Five operators placed the VOIs, using for guidance: a) SPECT/CT with RR, b) SPECT/CT without RR, and c) CT only. For simulated images, time-integrated ACs (TIACs) were evaluated. For patient images, estimated ACs were compared with results of a previous method based on whole-kidney VOIs.

Results: Eight iterations and ten subsets were sufficient for both programs and reconstruction settings. Mean RCs (mean ± SD) with RR were 1.03 ± 0.02 (LundaDose) and 1.10 ± 0.03 (Hermia), and without RR 0.91 ± 0.03 (LundaDose) and 0.94 ± 0.03 (Hermia). Most stable and accurate estimates of the AC were obtained using five 2-mL VOIs guided by SPECT/CT with RR, applying them to images without RR, and including an explicit RC for recovery correction.

Conclusion: The small VOI method based on five 2-mL VOIs was found efficient and sufficiently accurate for kidney dosimetry in [177Lu]Lu-DOTA-TATE therapy.

Keywords: (177)Lu-PRRT; Dosimetry; Kidneys; Quantitative SPECT.

MeSH terms

  • Heterocyclic Compounds, 1-Ring*
  • Humans
  • Kidney
  • Single Photon Emission Computed Tomography Computed Tomography
  • Tomography, Emission-Computed, Single-Photon* / methods

Substances

  • 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
  • Heterocyclic Compounds, 1-Ring